Subscribe to our Email Alerts
Neuren Pharmaceuticals
  • Home
  • About Us
    • Company Overview
    • Company Values
    • Board of Directors
    • Executive Management
    • Corporate Directory
  • Products
    • DAYBUE™ (trofinetide)
  • Pipeline
    • Pipeline
    • Trofinetide
      • Rett Syndrome
    • NNZ-2591
      • Phelan-McDermid Syndrome
      • Angelman Syndrome
      • Pitt Hopkins Syndrome
      • Hypoxic-ischemic encephalopathy
      • Prader-Willi Syndrome
  • Science
    • Science Behind Neuren's Products
    • Trofinetide Published Studies & Presentations
      • Rett Syndrome
    • NNZ-2591Published Studies & Presentations
      • Phelan-McDermid Syndrome
      • Pitt Hopkins Syndrome
      • Angelman Syndrome
  • Investors
    • Investor Dashboard
    • Share Price Information
    • ASX Announcements
    • Annual and Interim Reports
    • Investor Presentations
    • Corporate Governance
    • Analyst Coverage
    • Shareholder Services
  • News & Media
    • Media
  • Contact
    • Contact Us
    • Email Alerts

Investors

 

Home > Investors >
  • Investor Dashboard
  • Share Price Information
  • ASX Announcements
  • Annual and Interim Reports
  • Investor Presentations
  • Corporate Governance
  • Analyst Coverage
  • Shareholder Services

Analyst Coverage


 
22-Sep-2022    View Update Report: MST Access 27 September 2022  
 
27-Jul-2022    View Update Report: MST Access 27 July 2022  
 
18-Jul-2022    View Update Report: MST Access 18 July 2022  
 
30-Mar-2022    View Update Report: MST Access 30 March 2022  
 
14-Feb-2022    View Update Report: MST Access 14 February 2022  
 
12-Nov-2021    View Update Report 12 November 2021  
 
22-Sep-2021    View Extract - Edition 902 22 September 2021  
 
8-Sep-2021    View Extract - Edition 901 8 September 2021  
 
11-Aug-2021    View Update Report 11 August 2021  
 
11-Aug-2021    View Extract - Edition 899 11 August 2021  
 
15-Jun-2021    View Extract - Edition 895 15 June 2021  
 
19-Apr-2021    View Extract - Edition 888 19 April 2021  
 
18-Feb-2021    View Update Report 18 Feb 2021  
 
16-Feb-2021    View Update Report 16 Feb 2021  
 
5-Nov-2020    View Update Report 5 November 2020  
 
28-May-2020    View Update Report 28 May 2020  
 
14-Nov-2019    View Initiation Report 14 November 2019  
 

Quick Links

Contact Us

Neuren Pharmaceuticals Limited
Suite 201, 697 Burke Road
Camberwell, VIC 3124
Australia

Phone: +61 (3) 9092 0480
Email: enquiries@neurenpharma.com

Email Alerts

Subscribe to our Email Alerts

Follow Us

Copyright © Neuren Pharmaceuticals
Site Map Privacy Search
Site by